📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Sol-Gel Coatings Companies

Sol-gel Coatings Companies specialize in the production of coatings derived from sol-gel processes. These coatings find applications in industries such as electronics, optics, and aerospace, offering unique properties and performance advantages.

Sol-gel Coatings Key Companies

June 2023

The signing of exclusive licence agreements for TWYNEO and EPSOLAY for the Canadian market was announced today by Sol-Gel Technologies Ltd., an Israeli dermatology company, and Searchlight Pharma Inc., a private specialty pharmaceutical company in Canada. Sol-Gel is the creator of TWYNEO and EPSOLAY, two cutting-edge, widely available dermatology products. The U.S. launch of both products occurred recently, and Searchlight will commercialise in Canada for a fifteen-year period that can be extended for additional five-year periods.

For the treatment of acne vulgaris in adults and paediatric patients nine years of age and older, TWYNEO (tretinoin, 0.1% and benzoyl peroxide, 3% cream) is used. Adults with rosacea who have inflammatory lesions are treated with EPSOLAY (benzoyl peroxide, 5% cream).

Under the terms of the agreement, Sol-Gel will be compensated with potential upfront payments of up to $11 million as well as regulatory and sales milestones for the combined use of both drugs. Furthermore, Sol-Gel will be eligible to receive royalty percentages ranging from low double digits to high teens on all Canadian net sales.

With assistance from Sol-Gel, Searchlight will be in charge of securing and upholding any regulatory approvals necessary to promote and sell the medications in Canada.  

TWYNEO, which the FDA has approved for treating acne vulgaris in adults and paediatric patients nine years of age and older, and EPSOLAY, which the FDA has approved for treating inflammatory lesions of rosacea in adults, are products of Sol-Gel. Galderma is the only licence holder and distributor of both medications in the United States.

The above information focuses are simply identified with the organizations' center identified with sol-gel coatings market growth.

  • Akzo Nobel NV


  • 3M

  • PPG Industries

  • 3M

  • PPG Industries, Inc. 


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.